Suppr超能文献

基于过度诊断和过度治疗的潜在危害而拒绝乳房筛查和/或乳腺癌治疗的决定:一项定性研究

Decisions to decline breast screening and/or breast cancer treatment based on the potential harms of overdiagnosis and overtreatment: a qualitative study.

作者信息

Jeffers Shavez, Pilnick Alison, Armstrong Natalie

机构信息

Diabetes Research Centre, University of Leicester, Leicester, UK

School of Nursing and Public Health, Manchester Metropolitan University, Manchester, UK.

出版信息

BMJ Open. 2024 Dec 10;14(12):e089155. doi: 10.1136/bmjopen-2024-089155.

Abstract

OBJECTIVES

To explore the experiences of women who have made the decision to decline breast screening and/or breast cancer treatment for overdiagnosis/overtreatment reasons after being invited to the National Health Service Breast Screening Programme (NHS BSP).

DESIGN

Qualitative interview study using reflexive thematic analysis.

SETTING

Participants were recruited via social media, online forums and word of mouth. Semi-structured interviews were conducted between May 2021 and April 2022.

PARTICIPANTS

20 women aged between 49 and 76 years old who had declined one or more of the following after receiving an invitation to participate in the NHS BSP: (1) screening investigation, that is, mammogram; (2) further investigations, for example, biopsy, ultrasound; (3) treatment, for example, mastectomy, chemotherapy, radiotherapy and (4) any other medical intervention, for example, ongoing medication.

RESULTS

The three main themes were as follows: (1) the perception that the NHS BSP information was biased towards uptake and so constrained choice; (2) taking an active role in decision-making by considering the benefits and harms of the NHS BSP and (3) navigating potential regret for having declined.

CONCLUSIONS

In-depth understanding of the potential harms of overdiagnosis and overtreatment influenced the decision to decline for these participants and contributed to their dissatisfactions with the way that information was presented in the invitation to the NHS BSP and the women felt confident in their assessments of the benefits and harms. These findings differ from previous studies, which have suggested that the vast majority lack knowledge and understanding of what overdiagnosis and overtreatment are whereas the participants in this study demonstrated high levels of health literacy. Findings have implications for the way informed choice is considered and constructed in relation to the NHS BSP.

摘要

目的

探讨在被邀请参加国民医疗服务体系乳房筛查计划(NHS BSP)后,因过度诊断/过度治疗原因而决定拒绝乳房筛查和/或乳腺癌治疗的女性的经历。

设计

采用反思性主题分析的定性访谈研究。

背景

通过社交媒体、在线论坛和口碑招募参与者。2021年5月至2022年4月进行了半结构化访谈。

参与者

20名年龄在49岁至76岁之间的女性,她们在收到参加NHS BSP的邀请后拒绝了以下一项或多项:(1)筛查检查,即乳房X光检查;(2)进一步检查,例如活检、超声检查;(3)治疗,例如乳房切除术、化疗、放疗;以及(4)任何其他医疗干预,例如持续用药。

结果

三个主要主题如下:(1)认为NHS BSP的信息偏向于接受,从而限制了选择;(2)通过考虑NHS BSP的利弊在决策中发挥积极作用;(3)应对因拒绝而可能产生的遗憾。

结论

对过度诊断和过度治疗潜在危害的深入理解影响了这些参与者的拒绝决定,并导致她们对NHS BSP邀请中信息呈现的方式感到不满,而这些女性对自己对利弊的评估充满信心。这些发现与之前的研究不同,之前的研究表明绝大多数人缺乏对过度诊断和过度治疗的了解,而本研究的参与者表现出较高的健康素养水平。研究结果对与NHS BSP相关情况下知情选择的考虑和构建方式具有启示意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验